Intrathecal Clonidine Addiction for Combined Spinal Epidural Analgesia During Labor

NCT03018171 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 268

Last updated 2017-04-27

No results posted yet for this study

Summary

The study aims to evaluate the impact of the addition of 20 mcg of intrathecal clonidine in combined spinalepidural for labor analgesia on the local anesthetic consumption, on labor performance and on maternal fetal well-being.

Conditions

  • Labor Pain

Interventions

DRUG

Clonidine

Intrathecal clonidine addiction

DRUG

Sufentanil

Intrathecal

Sponsors & Collaborators

  • San Giovanni Calibita Fatebenefratelli Hospital

    lead OTHER

Principal Investigators

  • Claudia Claroni, MD · Fatebenefratelli San Giovanni Calibita - Tiberine Island

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03018171 on ClinicalTrials.gov